Rheumatology

Medicine & Life Sciences

1. Adrenal Cortex Hormones 5%
2. Antibodies 8%
3. Antineutrophil Cytoplasmic Antibodies 17%
4. Antiphospholipid Antibodies 12%
5. Antirheumatic Agents 6%
6. Arthritis 38%
7. Arthropathy, progressive pseudorheumatoid, of childhood 19%
8. Autoantibodies 10%
9. Autoimmune Diseases 8%
10. B-Lymphocytes 8%
11. Biomarkers 8%
12. Biopsy 6%
13. Body Mass Index 7%
14. Child 27%
15. Child Protective Services 5%
16. Chronic Kidney Failure 5%
17. Cohort Studies 15%
18. Connective Tissue Diseases 5%
19. Dendritic Cells 19%
20. Dermatomyositis 20%
21. Epidemiology 7%
22. Family Relations 6%
23. Glucocorticoids 12%
24. Granulomatosis with Polyangiitis 37%
25. Growth and Development 5%
26. HLA Antigens 5%
27. Hospitalization 6%
28. Insurance 5%
29. Interferon Type I 13%
30. Interleukin-10 8%
31. Interviews 5%
32. Juvenile Arthritis 33%
33. Juvenile-onset scleroderma 18%
34. Kidney 12%
35. Localized Scleroderma 34%
36. Lupus Nephritis 38%
37. Mi-2 antibodies 8%
38. Microscopic Polyangiitis 20%
39. Monocytes 8%
40. Muscles 6%
41. Myositis 20%
42. National Institutes of Health (U.S.) 5%
43. Natural History 9%
44. Nephritis 11%
45. Neutrophils 10%
46. Nucleic Acids 14%
47. Patient Transfer 7%
48. Pediatrics 66%
49. Population 6%
50. Registries 17%
51. Retrospective Studies 6%
52. Rheumatic Diseases 10%
53. Rheumatologists 18%
54. Rheumatology 91%
55. Sacroiliitis 7%
56. Succinic Acid 11%
57. Systemic Lupus Erythematosus 100%
58. T-Lymphocytes 7%
59. Therapeutics 15%
60. Transition to Adult Care 17%
61. Translational Medical Research 11%
62. Tumor Necrosis Factor-alpha 7%
63. Uveitis 12%
64. Vasculitis 27%
65. Venous Thrombosis 9%
66. Whole Genome Sequencing 5%
67. Wounds and Injuries 5%
68. Young Adult 8%